Ceva Santé Animale is a global veterinary health company focused on the research, development, production and marketing of pharmaceutical products and vaccines for companiion animals, livestock, swine and poultry. Founded in 1999, their expertise centres on the two fields of pharmacology and biology, where They have dedicated teams that aim to meet the specific demands of the companion animal, poultry, ruminant and swine sectors. They continually strive to find better solutions to existing and emerging diseases which will in turn improve animal health and productivity.
Their care extends beyond animal health and welfare. These days, a staggering 75% of all emerging human infectious diseases are of animal origin. Ceva is involved in the fight against the spread of infectious disease that can be transmitted from wild or domestic animals and birds to humans – diseases known as zoonoses, which include avian flu, brucellosis and Q-fever.
Ceva is a visible supporter of and contributor to various welfare and social programmes all over the world. Their work ranges from researching, developing, producing and supplying animal health products to the poorest livestock owners in the world, of which their SOS (Stamp Out Sleeping sickness) programme in Uganda is a good example; to supplying the UK’s largest dog welfare charity with Dog Appeasing Pheromone (Adaptil®) collars, to help make the lives of dogs in shelter less stressful.
Their global business operations are divided into six major zones: Western Europe, Central and Eastern Europe (incl. Turkey), North America, Latin America, Africa/Middle East and Asia/Pacific. They are directly present in 42 countries, have 13 research and development centres, 21 production sites and more than 3500 employees worldwide. The company is focused on the research, development, production and marketing of pharmaceutical products and vaccines for companion animal, poultry, ruminant and swine.
Research and Development
Their research teams are located around the world, as the need to find talented scientists, more than ever, knows no national boundaries. As a result, they have a global research and development (R&D) structure with pharmaceutical centres in Libourne (France), Paulínia (Brazil) and Cavriago (Italy). Their biology campuses are located in Kansas City (USA), Cuernavaca (Mexico), Campinas (Brazil), Budapest (Hungary) Tokyo (Japan), Beijing (China) and Buenos Aires (Argentina).
Ceva's decentralized structure allows each team great autonomy to develop their own ideas, while regular expert group meetings give their teams the opportunity to network internally as well as with the many external institutes, universities and private research groups that contribute significantly to their R&D programmes.
Vision: The health of animals, people and the planet are inextricably linked. The world needs a holistic approach to health, that understands that, by protecting the health of animals and their environment, they protect their own health and future.
Values:
They believe in customer passion, shaping each solution and the way they work around each customer’s specific business ambitions, needs and challenges. They build strong, long-term relationships and work as partners, innovating and developing new solutions together.
Their entrepreneurial spirit empowers individuals with the agility to deliver results faster and quicker. they share knowledge and take opportunities. They think and do things differently, creatively. All to find the best possible solutions for their customers.
Solidarity is about teamwork. Their shared purpose to combat the world’s major animal health challenges. They give individuals space to make decisions and they respect each other’s work. This extends into their customers’ worlds where they foster open, collaborative relationships.
Their innovation mindset keeps us focused on the highest quality and continuous improvement. It’s not just about product innovation but constantly challenging themselves to find new ways to create long-term value – for us and for their customers.
